-
12:10
-
10:30
-
09:00
-
15:02
-
15:00
-
14:44
-
14:00
-
11:45
-
09:15
Keywords: Semaglutide
China is set to include semaglutide, a GLP-1 medication used in diabetes care, on its national essential medicines list, a move aimed at improving access to advanced treatments across the country. The decision, announced by Chinese authorities on Thursday, will require public hospitals to prioritize......
Marrakesh, November 4, 2025 — The pharmaceutical company Novo Nordisk, in partnership with Laprophan Laboratories, has officially launched Semaglutide in Morocco — an innovative medication designed for patients with type 2 diabetes. The announcement was made......
New research presented at the European Society of Cardiology annual conference in Madrid suggests that weight loss drugs known as GLP-1 agonists could dramatically reduce the risk of hospitalisation and premature death in patients with heart conditions. The study analysed real-world data from over 90,000......
The World Health Organization (WHO) has issued a global alert regarding counterfeit medicines containing semaglutide, a drug used in the treatment of type 2 diabetes and obesity. This stern warning comes in the wake of the detection of falsified batches of semaglutide-based products across multiple countries,......